Patent · US Expired

Antiparkinson dosage form

US6217905A · kind A · utility

67Cited by
16References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 24, 1993
Grant dateApr 17, 2001
Priority date
Expiry dateMar 24, 2013

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/0004
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A dosage form is disclosed comprising an anti-Parkinson's disease drug for administering to a patient in need of anti-Parkinson's disease therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.